These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 35483599)
21. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma. Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y Front Immunol; 2021; 12():806189. PubMed ID: 35095893 [TBL] [Abstract][Full Text] [Related]
22. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma. Liu J; Zheng Z; Zhong J J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144 [TBL] [Abstract][Full Text] [Related]
23. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system. Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251 [TBL] [Abstract][Full Text] [Related]
24. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression. Li D; Fu Z; Dong C; Song Y Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574 [TBL] [Abstract][Full Text] [Related]
25. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer. Yu ZL; Zhu ZM Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333 [TBL] [Abstract][Full Text] [Related]
26. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433 [TBL] [Abstract][Full Text] [Related]
27. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance. Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098 [TBL] [Abstract][Full Text] [Related]
28. Alteration of N6-methyladenosine modification profiles in the neutrophilic RNAs following ischemic stroke. Fan J; Zhong L; Yan F; Li X; Li L; Zhao H; Han Z; Wang R; Tao Z; Zheng Y; Ma Q; Luo Y Neuroscience; 2024 Aug; 553():56-73. PubMed ID: 38945353 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of long non-coding RNA expression profiles of GC-1spg cells with m6A methylation knockdown. Zhong D; Yao C; Zhang L; Wang J; Liu Q; Shi D; Jiang M; Li H Gene; 2023 Jun; 871():147430. PubMed ID: 37062454 [TBL] [Abstract][Full Text] [Related]
30. Chronic allergic asthma alters m6A epitranscriptomic tagging of mRNAs and lncRNAs in the lung. Ni X; Li X; Hu B; Wang L Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36250525 [TBL] [Abstract][Full Text] [Related]
31. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer. Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884 [TBL] [Abstract][Full Text] [Related]
32. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology. Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507 [TBL] [Abstract][Full Text] [Related]
33. Cross-Talk between N6-Methyladenosine and Their Related RNAs Defined a Signature and Confirmed m6A Regulators for Diagnosis of Endometriosis. Wang X; Zhao X; Wang J; Wu H; Cheng Y; Guo Q; Liang T; Zhang G Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675186 [TBL] [Abstract][Full Text] [Related]
34. Global N Shao Y; Duan X; Zhao X; Lv Z; Li C Dev Comp Immunol; 2022 Aug; 133():104434. PubMed ID: 35562078 [TBL] [Abstract][Full Text] [Related]